DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations.
DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.8 percent.
This test has not been cleared or approved by the FDA. In our passionate pursuit to radically improve health outcomes, we serve humanity when we: Lead with Science, Anchor in Pragmatism : We pioneer life-changing science by ensuring quality, transparency, and rigor at all times. We explore thoughtfully, experiment smartly, and deliver impact with conviction. Build With & For All : We embrace diverse backgrounds to innovate and achieve together.
We are not just building a product - we aim to disrupt the path of cancer for all - no matter geography or socioeconomic class Put We over I : We are a home for high-performing people. Through teamwork, we build collective intelligence. Each of us wins when those we serve and those who serve with us--win. We show up with empathy, humility, and integrity at every step of the journey.
DELFI has 1-2 designated in-office working days each week for employees who live within within 50 miles of Palo Alto, CA What You'll Do Procure-to-Pay (P2P) End-to-end ownership of the P2P cycle: requisition, PO issuance, invoice matching, and payment Manage PO and invoice issues to ensure timely resolution Design and implement a scalable procurement process Recommend and implement automated solutions to support P2P Vendor onboarding, W-9/W-8 collection, ensuring valid vendor payment data, vendor master data integrity in NetSuite Manage relationships with AP-adjacent vendors (e.g., bill pay, corporate card providers) Monthly AP close activities: accruals, aging review, partner with FP&A to inform cash planning Work with R&D teams to understand projected order volumes and timing Sets re-order points and modify as the company expands Monitor critical vendors to ensure quoted prices are reasonable, including assisting with vendor consolidation and price negotiation related to high volume and high spend items Accounts Receivable (AR) Liaise with external vendor and internal customer experience team to reconcile AR on a monthly basis, including troubleshooting discrepancies with external vendor Generate and send invoices using NetSuite Liaise with internal customer experience team to ensure write-offs are recorded into NetSuite timely Expense Reports and Credit Cards Ensure proper onboarding and offboarding Timely approval of expenses Provide insight and analysis to FP&A on spend Work with vendors where needed to negotiate better prices on high spend areas General Accounting Monthly review of financials to ensure accuracy of PO coding to general ledger accounts and departments Journal entries and reconciliations for P2P, AR, expense report accrual, credit card accrual Demonstrate technical accounting knowledge through leveraging understanding of developments within the business to identify accounting risks in owned accoun